Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Graham

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
European Heart Journal|May 26, 2016
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)Massimo F Piepoli, Arno W Hoes, Stefan Agewall, et al.
Kardiologia Polska|September 23, 2016
[2016 European Guidelines on cardiovascular disease prevention in clinical practice]Massimo F Piepoli, Arno W Hoes, Stefan Agewall, et al.
Atherosclerosis|September 25, 2016
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Massimo F Piepoli, Arno W Hoes, et al.
Giornale Italiano Di Cardiologia (2006)|July 18, 2017
[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation]Massimo F Piepoli, Arno W Hoes, Stefan Agewall, et al.
Revista Espanola De Cardiologia (English Ed.)|October 4, 2016
2016 European Guidelines on cardiovascular disease prevention in clinical practiceMassimo F Piepoli, Arno W Hoes, Stefan Agewall, et al.
European Heart Journal|February 14, 2020
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, M John Chapman, Ronald M Krauss, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 7, 2021
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesSilvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, et al.
The Journal of the Association of Physicians of India|October 11, 2024
Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of IndiaRaman Puri, Vimal Mehta, Manish Bansal, et al.
BMC Pediatrics|August 19, 2022
Study protocol for Attachment & Child Health (ATTACH<sup>TM</sup>) program: promoting vulnerable Children's health at scaleLubna Anis, Nicole Letourneau, Kharah M Ross, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
European Heart Journal|May 26, 2016
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)Massimo F Piepoli, Arno W Hoes, Stefan Agewall, et al.
Kardiologia Polska|September 23, 2016
[2016 European Guidelines on cardiovascular disease prevention in clinical practice]Massimo F Piepoli, Arno W Hoes, Stefan Agewall, et al.
Atherosclerosis|September 25, 2016
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Massimo F Piepoli, Arno W Hoes, et al.
Giornale Italiano Di Cardiologia (2006)|July 18, 2017
[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation]Massimo F Piepoli, Arno W Hoes, Stefan Agewall, et al.
Revista Espanola De Cardiologia (English Ed.)|October 4, 2016
2016 European Guidelines on cardiovascular disease prevention in clinical practiceMassimo F Piepoli, Arno W Hoes, Stefan Agewall, et al.
European Heart Journal|February 14, 2020
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, M John Chapman, Ronald M Krauss, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 7, 2021
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesSilvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, et al.
The Journal of the Association of Physicians of India|October 11, 2024
Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of IndiaRaman Puri, Vimal Mehta, Manish Bansal, et al.
BMC Pediatrics|August 19, 2022
Study protocol for Attachment & Child Health (ATTACH<sup>TM</sup>) program: promoting vulnerable Children's health at scaleLubna Anis, Nicole Letourneau, Kharah M Ross, et al.
Pageof 17